Home > Insider Trading > Ascendis Pharma A/S

Ascendis Pharma A/S (ASND)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
21 - 30
Next >>

Ascendis Pharma A/S (NASDAQ:ASND) Q4 2022 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Ascendis Pharma Full Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

February 20th, 2023 - News Transcripts

What Makes Ascendis Pharma A/S (ASND) an Attractive Investment Choice?

Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.

Keep Reading →

January 30th, 2023 - Hedge Fund Investor Letters News

15 Most Advanced Countries in Europe

Over the course of recent human history, Europe has proven to be the bedrock of innovation.

Keep Reading →

December 29th, 2022 - Lists News Tech

Here's the Reason for the Healthy Performance of Ascendis Pharma A/S (ASND)

TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” third-quarter investor letter. A copy of the same can be downloaded here.

Keep Reading →

December 26th, 2022 - Hedge Fund Investor Letters News

5 Best Guru Stocks To Buy Now

The Allstate Corporation (NYSE:ALL) is an Illinois-based company that provides property, casualty, and other insurance products in the United States and Canada.

Keep Reading →

October 20th, 2022 - Hedge Funds News

15 Most Valuable Danish Companies in the World

In this article, we will take a look at 15 of the most valuable Danish companies in the world.

Keep Reading →

October 11th, 2022 - Hedge Funds Lists News

Here's Why Ascendis Pharma A/S (ASND) Became a Detractor in Artisan Partners' Portfolio

Artisan Partners, an investment management company, released its “Artisan Global Discovery Fund” second quarter investor letter. A copy of the same can be downloaded here.

Keep Reading →

September 27th, 2022 - Hedge Fund Investor Letters News

Artisan Partners 'Remains Quite Optimistic' in Ascendis Pharma (ASND)

Artisan Partners, a high value-added investment management firm, published its ‘Artisan Mid Cap Fund’ fourth quarter 2021 investor letter – a copy of which can be downloaded here.

Keep Reading →

February 25th, 2022 - Hedge Fund Investor Letters News

Hedge Funds Are Dumping Ascendis Pharma A/S (ASND)

As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.

Keep Reading →

December 11th, 2021 - Hedge Funds News

5 Pharmaceutical Stocks to Buy According to Peter Kolchinsky's RA Capital

In this piece, we will take a look at the top 5 pharmaceutical stocks to buy according to Peter Kolchinsky's RA Capital. If you want a comprehensive view of Dr.

Keep Reading →

November 25th, 2021 - Hedge Funds News